Noile-Immune Biotech Inc.
4893.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥7 | ¥9 | ¥28 | ¥29 |
| - Cash | ¥5 | ¥6 | ¥5 | ¥4 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥3 | ¥3 | ¥23 | ¥25 |
| Revenue | ¥0 | ¥0 | ¥1 | ¥0 |
| % Growth | -97.6% | -49.4% | 521.2% | – |
| Gross Profit | ¥0 | ¥0 | ¥1 | ¥0 |
| % Margin | 97.4% | 99.3% | 98.9% | 77.3% |
| EBITDA | -¥1 | -¥1 | -¥0 | -¥1 |
| % Margin | -14,092.3% | -244.7% | -17% | -761.9% |
| Net Income | -¥1 | -¥1 | -¥0 | -¥1 |
| % Margin | -12,711.9% | -356.7% | -61.8% | -789.3% |
| EPS Diluted | -22.26 | -27.25 | -9.87 | -19.33 |
| % Growth | 18.3% | -176.1% | 48.9% | – |
| Operating Cash Flow | -¥1 | -¥1 | -¥0 | -¥1 |
| Capital Expenditures | ¥0 | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | -¥1 | -¥1 | -¥0 | -¥1 |